Emesis in Medical Technology
ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease
... [1].
Phase I studies demonstrated good tolerability of EHT 0202 in both young
and aged healthy volunteers; importantly, no sedation or
emesis were observed
clinically.
Preclinical studies have shown that EHT 0202 protects cortical neurons
against Abeta42-induced stress and that this ...
Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
... is pleased with the results to date and is
confident that MGX006 will provide an important therapeutic alternative for
patients suffering from
emesis of various etiologies," continued Dr.
Scranton.
"MGX006 represents a key milestone for Victory," stated Matthew Heck,
President and CEO. "This ...
GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
... Cancer.
2004;100,10 :2261-2268.
(7) Hesketh PJ, et Al. Differential involvement of neurotransmitters
through the time course of cisplatin-induced
emesis as revealed by therapy
with specific receptor antagonists. Eur J Cancer. 2003; 39:1074-1080.
(8) Kris M. et. Al. Consensus proposals for the ...
Palatin Technologies and King Pharmaceuticals Report Data Showing
Improvements in Sexual Relationship and Self-Esteem in Patients
with Erectile Dysfunction Treated with Bremelanotide
... leading to patient discontinuation from the study were
nausea,
emesis and blood pressure increase.
emesis and blood
pressure increase were protocol-mandated reasons for ...
MGI Pharma Summarizes Data Presented at the 2007 American Society
of Clinical Oncology (ASCO) Annual Meeting
... of chemotherapy. Endpoints of the study included complete
response (no
emesis or rescue medication), no emesis, and no
significant nausea (Visual ... during the
overall period of Days 1-5.
On Day 1, 100% of patients had no
emesis and at least 95% of
patients had no emetic episodes in the delayed and ...
Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In
Absolute Bioavailability Study
... nanocochleate technology on Bioral Amphotericin
B targeting fungal infections and considering products targeted at
other acute conditions including
emesis and insomnia in the
BEMA(TM) technology. The company's headquarters are located in
Morrisville, North Carolina and its principal laboratory is ...
MGI Pharma, Inc. Summarizes Data Presented at the 2007 American
Society of Clinical Oncology (ASCO) Annual Meeting
... mg, oral
dexamethasone 20 mg and aprepitant 285 mg prior to their first
cycle of chemotherapy. Endpoints of the study included complete
response (no
emesis or rescue medication), no emesis, and no
significant nausea (Visual Analogue Score (VAS; 0-100) less than
25) on Day 1, during the delayed period of ...
Emesis in Medical Dictionary
Emesis
... Hyper
emesis gravidarum Definition: Hyper
emesis gravidarum is extreme, persi stent nausea and ... that may lead to dehydration . HEMAT
emesis - Vomiting blood . Commonly seen with a ...
Acidosis
... in the blood stream). metabolic disorder ... Heartburn ( Acidosis , Overacid Stomach ) Hiatal Hernia (Hiatus Hernia ) Vomiting (
emesis ) Indigestion ( Dyspepsia ) Dyspepsia (Poor Digestion ; Indigestion ) Nervous Dyspepsia [Kellogg] ... Respiratory acidosis develops ...
Heartburn
... breast bone and moves upward to the neck and throat. Heartburn ( Acidosis , Overacid Stomach ) Hiatal Hernia (Hiatus Hernia ) Vomiting (
emesis ) Indigestion ( Dyspepsia ) Dyspepsia (Poor Digestion ; Indigestion ) Nervous Dyspepsia [Kellogg] ... heartburn Indigestion . A ...
Nausea and vomiting
... for this content. Please discuss any and all treatment options with your healthcare professional. Nausea and Vomiting Alternate Names :
emesis , Stomach Upset, Upset Stomach , Vomiting Definition ... Nausea and vomiting . (Can often be controlled by taking the pill during a meal or ...
Pica
... specifically recommended for the treatment of leg cramps and other pregnancy -induced discomforts, such as anaemia, herpes , nausea and hyper
emesis , ( vomiting ) ptyalism (excessive saliva ), and pica ... [5] Complications of phlebotomy include progressive and sometimes extreme ...
Emesis in Biological Technology
Midwest life science stocks kept sizzling in Q2
... HQ. It appears likely that Cardinal will sell its campus just north of Abbott Park.
MGI Pharma announced the expansion of its fast-growing
emesis drug with new indications being sought from the FDA.
Biomet agreed to an $11.4 billion from a private equity group .
Deal surge
...